Idera Pharmaceuticals Inc (IDRA)

[FatCat_Banker]

It's a very professional way of saying: We think we have a cure for BCell leukemia/MW.

My take away:

In contrast, IMO-8400 treatment had no effects on control SU-DHL-6 cells in vitro or in vivo. Our studies show that IMO-8400 inhibits oncogenic MYD88 L265P-mediated cell survival and provides a novel approach for treatment of patients with this mutation. A Phase 1/2 trial of IMO-8400 in patients with WM is now open for enrollment.